Sign in
CVAC Stock Price, Chart, Stats & News
CureVac N.V.
Save
1.05B
Market cap
6.96x
Current P/E
5.24x
Forward P/E
CVAC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 93.00% |
Operating margin | 212.01% |
Pretax margin | 222.50% |
Net margin | 182.11% |
Effective tax rate | 18.15% |
ROA | 11.31% |
ROE | 18.40% |
D/E | 0.04x |
Interest coverage ratio | 20.89x |
CVAC valuation
P/E | 6.96x |
P/S | 12.86x |
P/B | 1.04x |
P/CF | -7.57x |
P/FCF | -7.27x |
P/OCF | -7.57x |
PEG | -0.24x |
EV multiple | 7.12x |
About
CureVac N. V. is a biopharmaceutical company currently in the clinical stage, specializing in creating innovative medical treatments leveraging messenger ribonucleic acid (mRNA) technology. Its portfolio encompasses various mRNA-based prophylactic vaccines.
Similar securities
Based on sector and market capitalization
Report issue